Issue of Equity and Total Voting Rights

Oxford Nanopore Technologies plc

23 October 2023

 

23 October 2023

Oxford Nanopore Technologies plc (the "Company")

Issue of Equity and Total Voting Rights

The Company today announces in respect of the period from 1 October to 23 October 2023, the issue of 29,200,350 ordinary shares of £0.0001 each ("Ordinary Shares"), following the subscription for 29,025,326 Ordinary Shares by bioMérieux SA in addition to the exercise of  options granted under the Company's share option plans and  issuance of  shares under certain of the Company's remuneration schemes.

Such Ordinary Shares were also admitted to the Official List of the Financial Conduct Authority ("FCA") and to trading on the London Stock Exchange's main market for listed securities.

175,024 ordinary Shares issued under the share option plans and remuneration schemes were made under the Company's block listing facility. Following this issue, the Company has the ability to admit a further 23,806,369 Ordinary Shares under its block listing facility.

In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, the Company announces that as at 23 October 2023, the Company's issued share capital consisted of  858,389,478  Ordinary Shares, one class A limited anti-takeover ("LAT") share of £1.00, one class B LAT share of £1.00 and one class C LAT share of £1.00. The Company did not hold any shares in treasury. Only the Ordinary Shares are voting shares and each such Ordinary Share carries one vote per Ordinary Share. Accordingly, the total number of voting rights in the Company as at 23 October 2023 is 858,389,478. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

Investors

[e-mail] 

Media 

[e-mail]

[e-mail]

 

END